Focus Group Interview Study on Patient Experiences and Satisfaction (RT_Focus)
Quality Improvement Actions on the Radiotherapy Ward: Focus Group Interview Study on Patient Experiences and Satisfaction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members. Following research questions will be answered:
- What elements of care (ie infrastructure, interpersonal contact, information, communication) are good to the opinion of patients and family members?
- What elements of care can be improved?
- What are priorities in improvement of the care for patients and families?
- What actions could possibly be taken in order to improve the care for future patients?
Because the radiotherapy ward exists of 3 clusters, one per type of treatment conducted, the investigators will perform 6 focus group interviews with patients (3 in the French, and 3 in the Dutch language) and 6 focus group interviews with family members (3 in the French, and 3 in the Dutch language).
Investigators will collect sex, main diagnosis (of patients), age and nationality of all participants at the beginning of each focus group interview. They will transcribe all interviews verbatim and analyze them in Nvivo software as provided by the VUB. Participant characteristics will be analyzed by descriptive statistics.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussel, Belgium, 1090
- UZ Brussel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria for patients:
- Patients (18+) who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
- Dutch and French speaking
- Start date of treatment max 6 months before inclusion
- Estimated sample size: 5-8 x 6 patients
Inclusion criteria for family members:
- All family members (+18) of patients who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
- Dutch and French speaking
- Start date of treatment of patient max 6 months before inclusion
- Estimated sample size: 5-8 x 6 family members
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient focus group
Patients who received radiation treatment
|
Group interview with patients who received radiation treatment
|
|
Experimental: Family focus group
Family of patients who received radiation treatment
|
Group interview with patients who received radiation treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of care
Time Frame: immediately after treatment
|
To identify elements of care that need improvement by using open ended interview questions and interaction between different participants
|
immediately after treatment
|
|
Problem solving
Time Frame: immediately after treatment
|
To identify solutions for problems in care by using open ended interview questions and interaction between different participants
|
immediately after treatment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2020-087
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.